How AI Is Aiming at the Bad Math of Drug Development

Artificial Intelligence In Drug Discovery

Exscientia Files For $100M IPO

European Biotech Investors Cap Off Record Year in Fundraising

Innovation at the intersection of design and technology

What’s big in A.I. this year

Artificial intelligence a key challenge for Germany's next government

Analyst reports trend in LS research funding

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Venture capitalists raise more than $100bn to target life sciences